Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04839497RecruitingPhase 2
Safety and benefit of injecting fibroblast cells in leg amputees’ skin
This Phase 2 study tests whether injecting a patient’s own (autologous) fibroblast cells into the end of a transtibial (below-knee) amputation is safe and may improve outcomes. You may qualify if you have a certain type of prosthesis timing and healthy skin on the stump, and you can follow frequent visit and wound-care instructions.
Baltimore, MarylandAges 18–75 - NCT03099850Recruiting
Studying chronic pancreatitis using follow-up tests
This study follows people with chronic pancreatitis to learn more about the disease and how to better diagnose it. You may have research-related scans or procedures and will be asked to stay in follow-up over time.
Houston, TexasAges 18–75 - NCT06105502Recruiting
Studying how therapy training helps students and patients
This trial looks at how training and supervision for new therapists affects their skills and patient outcomes. It may help improve how therapists are trained in public healthcare.
Stockholm, Stockholm CountyAges Any age - NCT06115642Enrolling by invitationPhase 1
Study of HLX43 for advanced solid tumors
This trial tests a new drug called HLX43 for people with advanced or metastatic solid tumors that have not responded to standard treatments. It aims to find safe dosing and understand how the drug works in the body.
Stanford, CaliforniaAges 18–75 - NCT06129240Recruiting
Study of a new inhaled treprostinil powder for PH-ILD
This study tests a new dry powder inhaled medicine called LIQ861 for people with pulmonary hypertension related to lung scarring (PH-ILD). If you are already taking an inhaled treprostinil treatment but need better control, this trial may help you switch to a potentially easier-to-use version.
Phoenix, ArizonaAges 18–80 - NCT06128447RecruitingPhase 3
New chewable drug for hookworm, roundworm and whipworm
This trial tests a new chewable tablet (ZP5-9676) to treat common intestinal worm infections. It compares the new drug to a placebo (fake pill) to see if it's safe and effective.
AmericaninhaAges 6 months–59 years - NCT06121297RecruitingPhase 1/Phase 2
CABA-201 treatment for systemic lupus erythematosus
This study tests a new treatment called CABA-201 for people with active systemic lupus erythematosus (SLE). The treatment aims to reduce disease activity and may help those who haven't responded well to other treatments.
Orange, CaliforniaAges 12–65 - NCT06121843RecruitingPhase 1
Study of CAR-T cell therapy in combinations for multiple myeloma
This trial tests a new CAR-T cell therapy (called arlocabtagene autoleucel) combined with other drugs for multiple myeloma that has returned or stopped responding. It aims to find a safe and effective dose while tracking how well the treatment works.
Birmingham, AlabamaAges 18 years+ - NCT06111638RecruitingPhase 2/Phase 3
Gene therapy for severe hemophilia A
This trial tests a gene therapy to help your body produce more of the clotting protein (factor VIII) it's missing. It may reduce or stop the need for regular factor infusions.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06124196Recruiting
Wearable device study for Duchenne muscular dystrophy
This study uses a wearable device to track your blood sugar levels and heart rate patterns over time. It aims to understand how these are related to Duchenne muscular dystrophy (DMD) and may help improve care.
Nashville, TennesseeAges 10 years+ - NCT06127784Recruiting
Survivorship program for head and neck cancer follow-up
This trial tests a new program to help people who finished treatment for head and neck cancer stay on track with follow-up care. You may be able to join if you completed treatment 3 to 6 months ago and your cancer has not spread.
London, OntarioAges 18 years+ - NCT06122337Recruiting
Finding causes of cardiac arrest in young adults
This study looks at why young adults have a cardiac arrest (when the heart suddenly stops pumping) outside the hospital, with no injury involved. It aims to better understand causes such as heart, genetic, or other medical issues.
TaipeiAges 18–60 - NCT06107361Recruiting
Guidewire use for ultrasound-guided IVs
This trial tests whether using a special guidewire during ultrasound-guided IV placement helps the IV last longer. It may be a good option if you have hard-to-find veins and need an IV.
Royal Oak, MichiganAges 18 years+ - NCT06126744RecruitingPhase 1
Study of a virus therapy for recurrent brain cancer
This trial tests a virus-based treatment called MVR-C5252 for people whose high-grade glioma or glioblastoma has come back after standard therapy. The virus is injected directly into the tumor to try to kill cancer cells and boost the immune system. The goal is to see if it is safe and if it can shrink the tumor.
New York, New YorkAges 18 years+ - NCT06058455Recruiting
Online sexual assault resistance program for college women
This trial tests an online program to help first- and second-year college women resist sexual assault. It aims to empower you with skills and support from peers.
Orlando, FloridaAges 17–24 - NCT04471909Recruiting
Stent graft for aortic arch problems in high-risk patients
This study tests a new stent graft device to treat problems in the aortic arch, such as aneurysms or chronic dissections, without open surgery. It may help people who are not good candidates for traditional open repair.
Birmingham, AlabamaAges 18 years+ - NCT06070454Recruiting
Study on infection and wound healing after vulvar surgery
This study looks at whether having an infection before surgery affects healing after removal of non-cancerous vulvar growths. It may help decide if treating infections first could lower complication rates.
Charlottesville, VirginiaAges 18 years+ - NCT05412069Recruiting
Test Fecobionics for fecal incontinence in adults
This trial studies whether Fecobionics can improve fecal incontinence (accidents with stool). It also looks at people with both “normal” and “abnormal” patterns of fecal incontinence to see who may benefit most.
San Diego, CaliforniaAges 18–75 - NCT06088004RecruitingPhase 1/Phase 2
ABO2011 for advanced solid tumors (phase 1/2)
This trial tests a new investigational drug called ABO2011, which is injected directly into tumors. It is for people with advanced solid tumors that have not responded to previous treatments. The goal is to see if the drug is safe and can help shrink or slow tumor growth.
BeijingAges 18 years+ - NCT06088121Recruiting
TMS with cognitive training for mild Alzheimer's dementia
This study tests a combination of brain stimulation (TMS) and cognitive training to improve memory and thinking in people with mild Alzheimer's. It may help if you are already on a stable dose of a donepezil-type medication and have a confirmed Alzheimer's diagnosis.
Incheon, Bupyeong 6(yuk)-dong, Bupyeong-guAges 60–85 - NCT06097156Recruiting
Automated blood test for breast cancer monitoring
This trial tests an automated device that prepares blood samples to detect cancer-related changes. It aims to improve how doctors monitor breast cancer that has spread, without needing a tissue biopsy every time.
MilanAges 18 years+ - NCT06084936RecruitingPhase 3
Glofitamab alone vs other treatments for mantle cell lymphoma
This trial tests a new drug called glofitamab to see if it works better than other standard treatments for people with mantle cell lymphoma that has come back or not responded to previous therapy. It is for patients who have already tried a BTK inhibitor and at least one other treatment.
Berkeley, CaliforniaAges 18 years+ - NCT06098534Recruiting
A new room design for elderly hospital patients
This study is testing a specially designed hospital room for older adults. If you are 75 or older and staying in a single room in the geriatric short-stay unit, this trial wants to see if the new room helps with comfort, safety, or recovery.
AngersAges 75 years+ - NCT04107285Recruiting
Study brain changes in people with lymphoma after CAR T
This study looks at how thinking and brain function change over time in people with lymphoma who receive CAR T therapy. It may help doctors understand side effects and better support patients during and after treatment.
New York, New YorkAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.